NCT05348083

Brief Summary

Management of pain after caesarean section represents an important anesthesiologic issue, since it is often suboptimal, leading to delayed functional recovery and chronic pain. Currently, the postoperative analgesic strategy mostly relies on intrathecal morphine (ITM) and multimodal analgesic regimen. Recently, the need for alterative opioid sparing techniques is emerging. Paraspinal fascial plane blocks, as quadratus lumborum block (QLB) and erector spinae plane block (ESPB) performed at T9 level, have therefore been proposed as alternatives to ITM, because of their demonstrated effect on visceral and somatic pain. The aim of the study is to assess the efficacy, the feasibility and safety of bilateral ESPB compared to bilateral QLB for the management of postoperative pain after ceasarean section conducted under spinal anesthesia without ITM.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 15, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

December 15, 2021

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 27, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2022

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2022

Completed
Last Updated

October 17, 2023

Status Verified

October 1, 2023

Enrollment Period

10 months

First QC Date

December 15, 2021

Last Update Submit

October 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Opioid consumption at 24 h

    Total morphine consumption at 24 hours from block performance

    24 hours from block performance

Secondary Outcomes (8)

  • Intensity of pain at time of block performance

    Time of block performance, at the end of surgery

  • Intensity of pain at 2 hours

    2 hours from block performance

  • Intensity of pain at 6 hours

    6 hours from block performance

  • Intensity of pain at 12 hours

    12 hours from block performance

  • Intensity of pain at 24 hours

    24 hours from block performance

  • +3 more secondary outcomes

Study Arms (2)

ESPB

A prospective cohort of 25 patients ASA 2 (according to American Society of Anesthesiologists physical status classification) with normal singleton pregnancy, scheduled for elective caesarean section under spinal anesthesia without intrathecal morphine, who underwent bilateral echo-guided ESPB at T9 level at the end of surgery.

Procedure: ESPB

p-QLB

A historical cohort of 25 patients ASA 2 (according to American Society of Anesthesiologists physical status classification) with normal singleton pregnancy, scheduled for elective caesarean section under spinal anesthesia without intrathecal morphine, who underwent bilateral echo-guided p-QLB at the end of surgery.

Interventions

ESPBPROCEDURE

Echo-guided bilateral ESPB performed at T9 level at the end of surgery with a mixture of ropivacaine 0.375% and epinephrine 5 mcg/mL 20 mL each side.

ESPB

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study is an observational comparative study, including a prospective cohort (the ESPB group) and a historical control group (the p-QLB group) from our institution.

You may qualify if:

  • \- Patients ASA 2 with normal singleton pregnancy, scheduled for elective caesarean section without intrathecal morphine, who underwent bilateral ESPB at the end of surgery an who gave informed consent to data collection.

You may not qualify if:

  • Contraindications to spinal anesthesia;
  • Contraindications to or a history of opioid dependence;
  • Allergy to local anesthetics, acetaminophen, NSAIDs
  • Inability to understand pain assessment scales or to use Patient Controlled Analgesia (PCA) pump;
  • Patient refusal.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Gemelli

Roma, RM, Italy

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physician Anesthesiologist

Study Record Dates

First Submitted

December 15, 2021

First Posted

April 27, 2022

Study Start

December 15, 2021

Primary Completion

October 20, 2022

Study Completion

October 30, 2022

Last Updated

October 17, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations